RL

Raman Lakshmi Sundaram

Active Director Director DIN 10407428
DIN 10407428 First appointment Nov 2023 Primary industry Professional Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Raman Lakshmi Sundaram

Data last updated:

Raman Lakshmi Sundaram is a Director at Rxtech Pharma Private Limited (since 2023). The company operates in Professional Services.

DIN 10407428
Primary Designation Director
Industry Professional Services
First Appointment 28 Nov 2023
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rxtech Pharma Private Limited U72100TN2023PTC165550
Director28 Nov 20232023Active

Board colleagues of Raman Lakshmi Sundaram

Directorship timeline

Open interactive timeline →
Rxtech Pharma Private Limited
Premium access

Shareholding and investment profile for Raman Lakshmi Sundaram

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raman Lakshmi Sundaram

Raman Lakshmi Sundaram currently holds 1 directorship: Rxtech Pharma Private Limited (Director, since 28 Nov 2023).

Raman Lakshmi Sundaram was first appointed on 28 Nov 2023 as Director at Rxtech Pharma Private Limited.

The current boards of Raman Lakshmi Sundaram's companies include Ayyadurai Jerad Suresh (Rxtech Pharma Private Limited), Murugesan Arumugam (Rxtech Pharma Private Limited), Satheshkumar Kesavan (Rxtech Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available